No Data
No Data
BioMarin Pharmaceutical (NASDAQ:BMRN) Could Easily Take On More Debt
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know wor
Biomarin Pharmaceutical(BMRN.US) Officer Sells US$375.95K in Common Stock
$Biomarin Pharmaceutical(BMRN.US)$ Officer Mueller Brian sold 5,000 shares of common stock on May 30, 2024 at an average price of $75.19 for a total value of $375.95K.Source: Announcement What is stat
Form 144 | Biomarin Pharmaceutical(BMRN.US) Insider Proposes to Sell 2.31 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 31, $Biomarin Pharmaceutical(BMRN.US)$ Insider BIENAIME JEAN JACQUES intends to sell 31,000 shares of its common stock on May 31, with a total market value of approximately
Analysts Conflicted on These Healthcare Names: Cooper Co (COO), Canopy Growth (CGC) and BioMarin Pharmaceutical (BMRN)
BioMarin Pharmaceutical Insider Sold Shares Worth $3,043,802, According to a Recent SEC Filing
George Eric Davis, Executive Vice President, Chief Legal Officer, on May 28, 2024, sold 40,850 shares in BioMarin Pharmaceutical (BMRN) for $3,043,802. Following the Form 4 filing with the SEC, Davis
Biomarin Pharmaceutical(BMRN.US) Officer Sells US$3.04 Million in Common Stock
$Biomarin Pharmaceutical(BMRN.US)$ Officer Davis George Eric sold 40,850 shares of common stock on May 28, 2024 at an average price of $74.512 for a total value of $3.04 million.Source: Announcement W
No Data